PTPA and neoplasm: In addition to inhibiting PP2A activity, E4orf4 could target substrates to the PP2A holoenzyme, or E4orf4 binding could even modify the substrate binding groove such that it could accommodate new substrates; however, we believe that these functions are probably not crucial for the selective killing of human tumor cells.